| Dec 22, 2010 |
Dec 22, 2010
Medicago updates on progress with Phase II clinical testing of its avian influenza vaccine candidate
|
| Dec 08, 2010 |
Dec 08, 2010
Medicago engages seasoned business development consultant
|
| Nov 26, 2010 |
Nov 26, 2010
Medicago announces an extension of its agreement with Genopole® biopark (Evry, France)
|
| Nov 12, 2010 |
Nov 12, 2010
MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS
|
| Nov 10, 2010 |
Nov 10, 2010
Medicago Awarded Funding from IRS (USA) Under Qualifying Therapeutic Discovery Project
|
| Nov 01, 2010 |
Nov 01, 2010
Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine
|
| Oct 21, 2010 |
Oct 21, 2010
Medicago Reduces Exercise Price of November 2009 Warrants
|
| Oct 13, 2010 |
Oct 13, 2010
Medicago and PATH collaborate on broad coverage influenza vaccines for the developing world
|
| Oct 01, 2010 |
Oct 01, 2010
Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility
|
| Sep 22, 2010 |
Sep 22, 2010
Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs and files two PCT patent applications
|
| Sep 08, 2010 |
Sep 08, 2010
Medicago announces a single low dose of its H5 VLP Vaccine achieves 100% cross-protection in lethal challenge study in ferrets
|
| Aug 31, 2010 |
Aug 31, 2010
Medicago named in Presidential report on meeting the challenges of pandemic influenza
|
| Aug 19, 2010 |
Aug 19, 2010
Medicago announces closing of its previously announced equity offering for gross proceeds of CAN$7.5 million
|
| Aug 13, 2010 |
Aug 13, 2010
Medicago announces 2010 second quarter financial results
|
| Aug 10, 2010 |
Aug 10, 2010
Medicago announces an increase of its previously announced equity offering to $7.5 million
|
| Aug 10, 2010 |
Aug 10, 2010
Medicago announces $7 million equity offering
|
| Aug 10, 2010 |
Aug 10, 2010
Medicago awarded $21 million from the U.S. Department of Defense
|
| Aug 09, 2010 |
Aug 09, 2010
Medicago Announces a Proposed Offering of Units
|
| Jun 23, 2010 |
Jun 23, 2010
Medicago Selected to Negotiate Final Terms with the Defense Advanced Research Projects Agency for Significant Funding Award
|
| Jun 14, 2010 |
Jun 14, 2010
Medicago signs MOU with PT BIO FARMA for the development of vaccines in the Republic of Indonesia
|
| May 14, 2010 |
May 14, 2010
Medicago announces 2010 first quarter financial results
|
| May 13, 2010 |
May 13, 2010
Standard & Poor's Announces Changes in the S&P/TSX Venture Composite Index
|
| May 13, 2010 |
May 13, 2010
Medicago announces graduation to the TSX and execution of a $10 million standby equity distribution agreement
|
| Apr 23, 2010 |
Apr 23, 2010
Medicago receives conditional approval to graduate to the TSX
|
| Mar 24, 2010 |
Mar 24, 2010
Medicago announces 2009 fourth quarter and year-end financial results
|
| Mar 18, 2010 |
Mar 18, 2010
Medicago announces results of warrant expiry
|
| Mar 16, 2010 |
Mar 16, 2010
Medicago signs MOU with NITT Partners for commercial development of influenza vaccines in Japan
|
| Mar 01, 2010 |
Mar 01, 2010
$300,000 Canadian Institutes of Health Research grant awarded to Medicago, McGill University and the Research Institute of the McGill University Health Centre
|
| Feb 17, 2010 |
Feb 17, 2010
Medicago invited to present at the 6th WHO's meeting on evaluation of pandemic influenza prototype vaccines in clinical trials
|
| Feb 05, 2010 |
Feb 05, 2010
Medicago named to TSX Venture 50
|
| Jan 20, 2010 |
Jan 20, 2010
Medicago provides corporate update
|